To elucidate the relationship between CERS4 expression and clinical prognosis in LumA breast cancer, Kaplan–Meier survival analyses were performed comparing LumA patients with higher CERS4 expression and those with lower CERS4 expression based on an optimal cutoff value. This evidence concerns the gene CERS4 and breast carcinoma.